ambruticin has been researched along with Histoplasmosis* in 1 studies
1 other study(ies) available for ambruticin and Histoplasmosis
Article | Year |
---|---|
Experimental chemotherapy of histoplasmosis in nude mice.
Nude (nu/nu) mice were infected with Histoplasma capsulatum and treated with varying doses of 3 drug regimens: oral ambruticin, intraperitoneal amphotericin B, and amphotericin B plus oral rifampin. Therapy with amphotericin B alone was the most effective regimen. High-dose ambruticin (50 mg/kg of body weight every 8 hours) led to significantly prolonged survival compared to that of untreated control animals, but no long-term cures. Addition of rifampin produced no benefit and might actually have decreased the efficacy of amphotericin B; this combination may be deleterious in a setting of immunodeficiency. Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Drug Evaluation, Preclinical; Drug Therapy, Combination; Histoplasmosis; Injections, Intraperitoneal; Mice; Mice, Nude; Pyrans | 1979 |